Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.61 |
| ▸ | IDO1 | P14902 | 2/20 | 0.61 |
| ▸ | CDC25A | P30304 | 2/20 | 0.61 |
| ▸ | PTPRC | P08575 | 1/20 | 0.56 |
| ▸ | GAPDH | P04406 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.51 |
| ▸ | SOAT1 | P35610 | 12/20 | 0.49 |
| ▸ | S100A4 | P26447 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9628020 | 0.92 | CDC25B (0.59) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL9444193 | 0.90 | CDC25B (0.57) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL9628579 | 0.89 | CDC25B (0.56) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL11247136 | 0.89 | CDC25B (0.56) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL9713908 | 0.89 | CDC25B (0.56) | CDC25BIDO1CDC25APTPRCGAPDH | |
| Naphthoquinone SCHEMBL28157298 | 0.86 | CDC25B (0.53) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL29800450 | 0.86 | CDC25B (0.74) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL2511730 | 0.86 | CDC25B (0.74) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL11246332 | 0.85 | CDC25B (0.56) | CDC25BIDO1CDC25APTPRCGAPDH | |
| SCHEMBL10446602 | 0.85 | CDC25B (0.64) | CDC25BIDO1CDC25APTPRCGAPDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4324852-A | REDOX COUPLES | EASTMAN KODAK COMPANY (US) | 1982-04-13 | — | — | US | claimed |
| US-4201588-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | claimed |
| US-4195998-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, QUINONE OR CARBAZIDE PHOTOREDUCTANT | EASTMAN KODAK COMPANY (US) | 1980-04-01 | — | — | US | claimed |
| US-7842840-B2 | Process for the preparation of trans-2,3-disubstituted naphthoquinones | LABORATORIO CHIMICO INTERNAZIONALE, S.P.A. (IT) | 2010-11-30 | — | — | US | disclosed |
| US-20100137644-A1 | Process for the preparation of trans-2,3-disubstituted naphthoquinones | LABORATORIO CHIMICO INTERNAZIONALE, S.P.A. (IT) | 2010-06-03 | — | — | US | disclosed |
| US-5155132-A | Nonsteroidal antiinflammatory agents; treating psoriasis | SYNTEX (U.S.A.) INC. (US) | 1992-10-13 | — | — | US | disclosed |
| US-5134161-A | Enzyme inhibitors for skin disorders, antiinflammatory agents | SYNTEX (U.S.A.) INC. (US) | 1992-07-28 | — | — | US | disclosed |
| US-5091558-A | Topical administeration | SYNTEX (U.S.A.) INC. (US) | 1992-02-25 | — | — | US | disclosed |
| US-5089657-A | Topical antiinflammatory agents | SYNTEX (U.S.A.) INC. (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0383536-A2 | Thermo-sensitive transfer printing medium | SEIKO INSTRUMENTS INC. (JP) | 1990-08-22 | — | — | EP | disclosed |
| US-4786652-A | TOPICAL ADMINISTRATION | SYNTEX (U.S.A.) INC. (US) | 1988-11-22 | — | — | US | disclosed |
| EP-0282056-A2 | Naphthalene anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1988-09-14 | — | — | EP | disclosed |
| EP-0150831-B1 | NAPHTHALENE ANTI-PSORIATIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1988-08-10 | — | — | EP | disclosed |
| US-4758587-A | Naphthalene anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1988-07-19 | — | — | US | disclosed |
| EP-0150831-A2 | Naphthalene anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1985-08-07 | — | — | EP | disclosed |
| EP-0099146-A2 | Film and composition for forming an image and method for recording electromagnetic radiation | ENERGY CONVERSION DEVICES, INC. (US) | 1984-01-25 | — | — | EP | disclosed |
| US-4332884-A | USING A DIOXIME CHELATING AGENT | RICOH CO., LTD. (JP) | 1982-06-01 | — | — | US | disclosed |
| US-4306014-A | AMMONIA OR AMINES SUPPRESS THE COLOR-FORMING REACTION SYSTEM | RICOH CO., LTD. (JP) | 1981-12-15 | — | — | US | disclosed |
| US-4201588-A | NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
| US-4171221-A | NONSILVER PHOTOGTAPHY | EASTMAN KODAK COMPANY (US) | 1979-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137644-A1 | Process for the preparation of trans-2,3-disubstituted naphthoquinones | NQO1, POLQ, SQLE | CDC25B 235/4885IDO1 2247/4885CDC25A 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.